Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2022

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

L.A. McKeown

September 18, 2022

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2015

Global TAVR Market Poised to Exceed DES Market by 2025

October 11, 2015

News Conference News TCT 2014

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

September 13, 2014

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

Presentation TCT 2013

Impact Of Transcatheter Aortic Valve Implantation On Mitral Regurgitation. Insights From A Multicenter Study.

Presenter: Konstantinos Toutouzas, Antonios Karanasos, Konstantinos Spargias, Konstantinos Stathogiannis, George Latsios, Andreas Synetos, Michalis Chrisoheris, Antonios Chalapas, Aias Antoniades, Gregory Pavlides, Christodoulos Stefanadis

January 31, 2013

Advertisement

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Global TAVR Market Poised to Exceed DES Market by 2025

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

Two Trials to Assess TAVR in Moderate-Risk Patients

Impact Of Transcatheter Aortic Valve Implantation On Mitral Regurgitation. Insights From A Multicenter Study.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content